位置:首页 > 蛋白库 > NFS1_HUMAN
NFS1_HUMAN
ID   NFS1_HUMAN              Reviewed;         457 AA.
AC   Q9Y697; B3KMA5; B4DXK9; E1P5R8; F5GYK5; Q6P0L8; Q9NTZ5; Q9Y481;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 3.
DT   03-AUG-2022, entry version 202.
DE   RecName: Full=Cysteine desulfurase, mitochondrial {ECO:0000305};
DE            EC=2.8.1.7 {ECO:0000269|PubMed:18650437};
DE   Flags: Precursor;
GN   Name=NFS1 {ECO:0000303|PubMed:18650437, ECO:0000312|HGNC:HGNC:15910};
GN   Synonyms=NIFS {ECO:0000303|PubMed:9885568}; ORFNames=HUSSY-08;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CYTOPLASMIC), ALTERNATIVE INITIATION,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9885568; DOI=10.1016/s1097-2765(00)80295-6;
RA   Land T., Rouault T.A.;
RT   "Targeting of a human iron-sulfur cluster assembly enzyme, nifs, to
RT   different subcellular compartments is regulated through alternative AUG
RT   utilization.";
RL   Mol. Cell 2:807-815(1998).
RN   [2]
RP   SEQUENCE REVISION TO 380-402.
RA   Land T., Rouault T.A.;
RL   Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS CYTOPLASMIC AND 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CYTOPLASMIC).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 140-457 (ISOFORM CYTOPLASMIC).
RX   PubMed=11124703;
RX   DOI=10.1002/1097-0061(200101)18:1<69::aid-yea647>3.0.co;2-h;
RA   Stanchi F., Bertocco E., Toppo S., Dioguardi R., Simionati B., Cannata N.,
RA   Zimbello R., Lanfranchi G., Valle G.;
RT   "Characterization of 16 novel human genes showing high similarity to yeast
RT   sequences.";
RL   Yeast 18:69-80(2001).
RN   [8]
RP   INTERACTION WITH ISCU.
RX   PubMed=11060020; DOI=10.1093/emboj/19.21.5692;
RA   Tong W.-H., Rouault T.;
RT   "Distinct iron-sulfur cluster assembly complexes exist in the cytosol and
RT   mitochondria of human cells.";
RL   EMBO J. 19:5692-5700(2000).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   INTERACTION WITH LYRM4.
RX   PubMed=18650437; DOI=10.1074/jbc.m804064200;
RA   Marelja Z., Stoecklein W., Nimtz M., Leimkuehler S.;
RT   "A novel role for human Nfs1 in the cytoplasm: Nfs1 acts as a sulfur donor
RT   for MOCS3, a protein involved in molybdenum cofactor biosynthesis.";
RL   J. Biol. Chem. 283:25178-25185(2008).
RN   [10]
RP   INTERACTION WITH LYRM4, AND SUBCELLULAR LOCATION.
RX   PubMed=19454487; DOI=10.1093/hmg/ddp239;
RA   Shi Y., Ghosh M.C., Tong W.H., Rouault T.A.;
RT   "Human ISD11 is essential for both iron-sulfur cluster assembly and
RT   maintenance of normal cellular iron homeostasis.";
RL   Hum. Mol. Genet. 18:3014-3025(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   INTERACTION WITH HSPA9, AND SUBCELLULAR LOCATION.
RX   PubMed=26702583; DOI=10.1016/j.mito.2015.12.005;
RA   Shan Y., Cortopassi G.;
RT   "Mitochondrial Hspa9/Mortalin regulates erythroid differentiation via iron-
RT   sulfur cluster assembly.";
RL   Mitochondrion 26:94-103(2016).
RN   [14]
RP   VARIANT COXPD52 GLN-72, INVOLVEMENT IN COXPD52, AND CHARACTERIZATION OF
RP   VARIANT COXPD52 GLN-72.
RX   PubMed=24498631; DOI=10.1002/mgg3.46;
RA   Farhan S.M., Wang J., Robinson J.F., Lahiry P., Siu V.M., Prasad C.,
RA   Kronick J.B., Ramsay D.A., Rupar C.A., Hegele R.A.;
RT   "Exome sequencing identifies NFS1 deficiency in a novel Fe-S cluster
RT   disease, infantile mitochondrial complex II/III deficiency.";
RL   Mol. Genet. Genomic Med. 2:73-80(2014).
RN   [15]
RP   VARIANT COXPD52 GLN-72, AND INVOLVEMENT IN COXPD52.
RX   PubMed=33457206; DOI=10.1016/j.ymgmr.2020.100699;
RG   Regeneron Genetics Center;
RA   Hershkovitz T., Kurolap A., Tal G., Paperna T., Mory A., Staples J.,
RA   Brigatti K.W., Gonzaga-Jauregui C., Dumin E., Saada A., Mandel H.,
RA   Baris Feldman H.;
RT   "A recurring NFS1 pathogenic variant causes a mitochondrial disorder with
RT   variable intra-familial patient outcomes.";
RL   Mol. Genet. Metab. Rep. 26:100699-100699(2021).
CC   -!- FUNCTION: Catalyzes the removal of elemental sulfur from cysteine to
CC       produce alanine (PubMed:18650437). It supplies the inorganic sulfur for
CC       iron-sulfur (Fe-S) clusters. May be involved in the biosynthesis of
CC       molybdenum cofactor (PubMed:18650437). {ECO:0000269|PubMed:18650437}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[sulfur carrier]-H + L-cysteine = [sulfur carrier]-SH + L-
CC         alanine; Xref=Rhea:RHEA:43892, Rhea:RHEA-COMP:14737, Rhea:RHEA-
CC         COMP:14739, ChEBI:CHEBI:29917, ChEBI:CHEBI:35235, ChEBI:CHEBI:57972,
CC         ChEBI:CHEBI:64428; EC=2.8.1.7;
CC         Evidence={ECO:0000269|PubMed:18650437};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000250|UniProtKB:O29689};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=434.75 uM for L-cysteine {ECO:0000269|PubMed:18650437};
CC         Note=Kinetic parameter was determined for the protein lacking the 55
CC         N-terminal amino acids and in a complex with LYRM4.
CC         {ECO:0000269|PubMed:18650437};
CC   -!- SUBUNIT: Binds ISCU/NIFUN (PubMed:11060020). Forms a complex with LYRM4
CC       (PubMed:18650437, PubMed:19454487). Interacts with HSPA9
CC       (PubMed:26702583). {ECO:0000269|PubMed:11060020,
CC       ECO:0000269|PubMed:18650437, ECO:0000269|PubMed:19454487,
CC       ECO:0000269|PubMed:26702583}.
CC   -!- INTERACTION:
CC       Q9Y697; Q9NZJ6: COQ3; NbExp=3; IntAct=EBI-1751791, EBI-10897372;
CC       Q9Y697; Q9HD34: LYRM4; NbExp=8; IntAct=EBI-1751791, EBI-3920810;
CC   -!- SUBCELLULAR LOCATION: [Isoform Mitochondrial]: Mitochondrion
CC       {ECO:0000269|PubMed:19454487, ECO:0000269|PubMed:26702583,
CC       ECO:0000269|PubMed:9885568}.
CC   -!- SUBCELLULAR LOCATION: [Isoform Cytoplasmic]: Cytoplasm
CC       {ECO:0000269|PubMed:9885568}. Nucleus {ECO:0000269|PubMed:19454487,
CC       ECO:0000269|PubMed:9885568}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=3;
CC         Comment=Individual cells may vary AUG utilization in accordance with
CC         changes in metabolic status, the cytosolic pH being a strong
CC         determinant of this modulation.;
CC       Name=Mitochondrial;
CC         IsoId=Q9Y697-1; Sequence=Displayed;
CC       Name=Cytoplasmic;
CC         IsoId=Q9Y697-2; Sequence=VSP_018646;
CC       Name=3;
CC         IsoId=Q9Y697-3; Sequence=VSP_045860;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in heart and skeletal
CC       muscle. Also found in brain, liver and pancreas.
CC       {ECO:0000269|PubMed:9885568}.
CC   -!- DISEASE: Combined oxidative phosphorylation deficiency 52 (COXPD52)
CC       [MIM:619386]: An autosomal recessive mitochondrial disorder with onset
CC       in infancy, characterized by lactic acidemia, hypotonia, respiratory
CC       chain complex II and III deficiency, multisystem organ failure and
CC       abnormal mitochondria. {ECO:0000269|PubMed:24498631,
CC       ECO:0000269|PubMed:33457206}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-V pyridoxal-phosphate-dependent
CC       aminotransferase family. NifS/IscS subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF097025; AAD09187.2; -; mRNA.
DR   EMBL; AK001470; BAG50917.1; -; mRNA.
DR   EMBL; AK302023; BAG63421.1; -; mRNA.
DR   EMBL; AL109827; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357374; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW76170.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW76172.1; -; Genomic_DNA.
DR   EMBL; BC065560; AAH65560.1; -; mRNA.
DR   EMBL; AJ010952; CAA09424.1; -; mRNA.
DR   CCDS; CCDS13262.1; -. [Q9Y697-1]
DR   CCDS; CCDS56185.1; -. [Q9Y697-3]
DR   RefSeq; NP_001185918.1; NM_001198989.1. [Q9Y697-3]
DR   RefSeq; NP_066923.3; NM_021100.4. [Q9Y697-1]
DR   PDB; 5KZ5; EM; 14.30 A; 1/2/3/4/M/N/O/P/Q/R/S/T=67-457.
DR   PDB; 5USR; X-ray; 3.09 A; A/C/E/G=56-457.
DR   PDB; 5WGB; X-ray; 2.75 A; A=56-457.
DR   PDB; 5WKP; X-ray; 3.15 A; A/E=56-457.
DR   PDB; 5WLW; X-ray; 3.32 A; A/E=56-457.
DR   PDB; 6NZU; EM; 3.20 A; A/E=55-457.
DR   PDB; 6UXE; X-ray; 1.57 A; A=56-457.
DR   PDB; 6W1D; X-ray; 1.79 A; A=56-457.
DR   PDB; 6WI2; X-ray; 1.95 A; A=56-457.
DR   PDB; 6WIH; X-ray; 1.90 A; A=56-457.
DR   PDB; 7RTK; X-ray; 2.50 A; A=56-457.
DR   PDBsum; 5KZ5; -.
DR   PDBsum; 5USR; -.
DR   PDBsum; 5WGB; -.
DR   PDBsum; 5WKP; -.
DR   PDBsum; 5WLW; -.
DR   PDBsum; 6NZU; -.
DR   PDBsum; 6UXE; -.
DR   PDBsum; 6W1D; -.
DR   PDBsum; 6WI2; -.
DR   PDBsum; 6WIH; -.
DR   PDBsum; 7RTK; -.
DR   AlphaFoldDB; Q9Y697; -.
DR   SASBDB; Q9Y697; -.
DR   SMR; Q9Y697; -.
DR   BioGRID; 114516; 132.
DR   ComplexPortal; CPX-5641; Mitochondrial NIAUFX iron-sulfur cluster assembly complex.
DR   IntAct; Q9Y697; 50.
DR   MINT; Q9Y697; -.
DR   STRING; 9606.ENSP00000363205; -.
DR   DrugBank; DB00160; Alanine.
DR   DrugBank; DB00151; Cysteine.
DR   DrugBank; DB00114; Pyridoxal phosphate.
DR   GlyGen; Q9Y697; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9Y697; -.
DR   PhosphoSitePlus; Q9Y697; -.
DR   SwissPalm; Q9Y697; -.
DR   BioMuta; NFS1; -.
DR   DMDM; 62512153; -.
DR   EPD; Q9Y697; -.
DR   jPOST; Q9Y697; -.
DR   MassIVE; Q9Y697; -.
DR   MaxQB; Q9Y697; -.
DR   PaxDb; Q9Y697; -.
DR   PeptideAtlas; Q9Y697; -.
DR   PRIDE; Q9Y697; -.
DR   ProteomicsDB; 24766; -.
DR   ProteomicsDB; 86633; -. [Q9Y697-1]
DR   ProteomicsDB; 86634; -. [Q9Y697-2]
DR   Antibodypedia; 35035; 233 antibodies from 26 providers.
DR   DNASU; 9054; -.
DR   Ensembl; ENST00000374085.5; ENSP00000363198.1; ENSG00000244005.13. [Q9Y697-2]
DR   Ensembl; ENST00000374092.9; ENSP00000363205.3; ENSG00000244005.13. [Q9Y697-1]
DR   Ensembl; ENST00000397425.5; ENSP00000380570.1; ENSG00000244005.13. [Q9Y697-2]
DR   Ensembl; ENST00000541387.5; ENSP00000440897.1; ENSG00000244005.13. [Q9Y697-3]
DR   GeneID; 9054; -.
DR   KEGG; hsa:9054; -.
DR   MANE-Select; ENST00000374092.9; ENSP00000363205.3; NM_021100.5; NP_066923.3.
DR   UCSC; uc002xdt.3; human. [Q9Y697-1]
DR   CTD; 9054; -.
DR   DisGeNET; 9054; -.
DR   GeneCards; NFS1; -.
DR   HGNC; HGNC:15910; NFS1.
DR   HPA; ENSG00000244005; Low tissue specificity.
DR   MalaCards; NFS1; -.
DR   MIM; 603485; gene.
DR   MIM; 619386; phenotype.
DR   neXtProt; NX_Q9Y697; -.
DR   OpenTargets; ENSG00000244005; -.
DR   Orphanet; 397593; Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency.
DR   PharmGKB; PA31607; -.
DR   VEuPathDB; HostDB:ENSG00000244005; -.
DR   eggNOG; KOG1549; Eukaryota.
DR   GeneTree; ENSGT00940000155740; -.
DR   HOGENOM; CLU_003433_0_2_1; -.
DR   InParanoid; Q9Y697; -.
DR   OMA; KGLYWAR; -.
DR   PhylomeDB; Q9Y697; -.
DR   TreeFam; TF105658; -.
DR   BioCyc; MetaCyc:HS01304-MON; -.
DR   BRENDA; 2.8.1.7; 2681.
DR   PathwayCommons; Q9Y697; -.
DR   Reactome; R-HSA-1362409; Mitochondrial iron-sulfur cluster biogenesis. [Q9Y697-1]
DR   Reactome; R-HSA-947581; Molybdenum cofactor biosynthesis. [Q9Y697-2]
DR   SignaLink; Q9Y697; -.
DR   SIGNOR; Q9Y697; -.
DR   BioGRID-ORCS; 9054; 662 hits in 1058 CRISPR screens.
DR   ChiTaRS; NFS1; human.
DR   GeneWiki; NFS1; -.
DR   GenomeRNAi; 9054; -.
DR   Pharos; Q9Y697; Tbio.
DR   PRO; PR:Q9Y697; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9Y697; protein.
DR   Bgee; ENSG00000244005; Expressed in right adrenal gland cortex and 178 other tissues.
DR   ExpressionAtlas; Q9Y697; baseline and differential.
DR   Genevisible; Q9Y697; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HGNC-UCL.
DR   GO; GO:1990229; C:iron-sulfur cluster assembly complex; IC:ComplexPortal.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:HGNC-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HGNC-UCL.
DR   GO; GO:0031071; F:cysteine desulfurase activity; IDA:HGNC-UCL.
DR   GO; GO:0051536; F:iron-sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:HGNC-UCL.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0044571; P:[2Fe-2S] cluster assembly; IEA:InterPro.
DR   GO; GO:0018283; P:iron incorporation into metallo-sulfur cluster; IDA:HGNC-UCL.
DR   GO; GO:0016226; P:iron-sulfur cluster assembly; IBA:GO_Central.
DR   GO; GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   HAMAP; MF_00331; Cys_desulf_IscS; 1.
DR   InterPro; IPR000192; Aminotrans_V_dom.
DR   InterPro; IPR020578; Aminotrans_V_PyrdxlP_BS.
DR   InterPro; IPR010240; Cys_deSase_IscS.
DR   InterPro; IPR016454; Cysteine_dSase.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   PANTHER; PTHR11601:SF34; PTHR11601:SF34; 1.
DR   Pfam; PF00266; Aminotran_5; 1.
DR   PIRSF; PIRSF005572; NifS; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   TIGRFAMs; TIGR02006; IscS; 1.
DR   PROSITE; PS00595; AA_TRANSFER_CLASS_5; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Alternative splicing; Cytoplasm;
KW   Disease variant; Iron; Iron-sulfur; Metal-binding; Mitochondrion;
KW   Molybdenum cofactor biosynthesis; Nucleus; Primary mitochondrial disease;
KW   Pyridoxal phosphate; Reference proteome; Transferase; Transit peptide.
FT   TRANSIT         1..?
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           ?..457
FT                   /note="Cysteine desulfurase, mitochondrial"
FT                   /id="PRO_0000001292"
FT   ACT_SITE        381
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:P0A6B7"
FT   BINDING         127..128
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000250|UniProtKB:P0A6B9"
FT   BINDING         207
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000250|UniProtKB:O29689"
FT   BINDING         235
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000250|UniProtKB:P0A6B9"
FT   BINDING         255..257
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000250|UniProtKB:P0A6B9"
FT   BINDING         295
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000250|UniProtKB:P0A6B9"
FT   BINDING         381
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_note="ligand shared with ISCU"
FT                   /note="via persulfide group"
FT                   /evidence="ECO:0000250|UniProtKB:O29689"
FT   MOD_RES         258
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P0A6B9"
FT   VAR_SEQ         1..60
FT                   /note="Missing (in isoform Cytoplasmic)"
FT                   /evidence="ECO:0000303|PubMed:11124703,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9885568"
FT                   /id="VSP_018646"
FT   VAR_SEQ         136..186
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045860"
FT   VARIANT         72
FT                   /note="R -> Q (in COXPD52; decreased protein expression in
FT                   homozygous patient cells)"
FT                   /evidence="ECO:0000269|PubMed:24498631,
FT                   ECO:0000269|PubMed:33457206"
FT                   /id="VAR_085966"
FT   CONFLICT        5
FT                   /note="A -> V (in Ref. 1; AAD09187)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        47
FT                   /note="A -> T (in Ref. 1; AAD09187)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        197
FT                   /note="T -> A (in Ref. 3; BAG63421)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        412
FT                   /note="R -> A (in Ref. 1; AAD09187)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        431
FT                   /note="K -> N (in Ref. 1; AAD09187)"
FT                   /evidence="ECO:0000305"
FT   TURN            63..65
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           71..82
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           94..114
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           118..120
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          121..125
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           127..141
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   TURN            142..145
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          148..152
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           157..168
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          172..176
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           186..192
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          197..201
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   TURN            207..209
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           215..224
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          228..232
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   TURN            234..239
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   TURN            244..248
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          250..255
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           256..258
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          266..270
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   TURN            272..275
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   TURN            287..291
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           298..336
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          337..344
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           346..348
FT                   /evidence="ECO:0007829|PDB:7RTK"
FT   STRAND          353..358
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           363..369
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          376..378
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           380..382
FT                   /evidence="ECO:0007829|PDB:6WIH"
FT   TURN            384..386
FT                   /evidence="ECO:0007829|PDB:6WIH"
FT   HELIX           390..394
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           399..402
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          405..409
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           416..435
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           438..444
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           449..451
FT                   /evidence="ECO:0007829|PDB:6UXE"
SQ   SEQUENCE   457 AA;  50196 MW;  FDE76177DB6E751B CRC64;
     MLLRAAWRRA AVAVTAAPGP KPAAPTRGLR LRVGDRAPQS AVPADTAAAP EVGPVLRPLY
     MDVQATTPLD PRVLDAMLPY LINYYGNPHS RTHAYGWESE AAMERARQQV ASLIGADPRE
     IIFTSGATES NNIAIKGVAR FYRSRKKHLI TTQTEHKCVL DSCRSLEAEG FQVTYLPVQK
     SGIIDLKELE AAIQPDTSLV SVMTVNNEIG VKQPIAEIGR ICSSRKVYFH TDAAQAVGKI
     PLDVNDMKID LMSISGHKIY GPKGVGAIYI RRRPRVRVEA LQSGGGQERG MRSGTVPTPL
     VVGLGAACEV AQQEMEYDHK RISKLSERLI QNIMKSLPDV VMNGDPKHHY PGCINLSFAY
     VEGESLLMAL KDVALSSGSA CTSASLEPSY VLRAIGTDED LAHSSIRFGI GRFTTEEEVD
     YTVEKCIQHV KRLREMSPLW EMVQDGIDLK SIKWTQH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024